Conglian Yang
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
Papers in
-
- Nanoplatforms for cancer theranostics 25
- Graphene and Nanomaterials Applications 5
- Immunology 23
- Immunotherapy and Immune Responses 14
- Immune cells in cancer 7
- Co-authors
- Zhiping Zhang (28 shared papers)Tingting Wu (7 shared papers)Li Kong (34 shared papers)Zhiping Zhang (18 shared papers)Yan Qi (3 shared papers)Qi Qiao (10 shared papers)Xianya Qin (14 shared papers)Lihuan Shang (5 shared papers)
In The Last Decade
Conglian Yang
47 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 108
- Biomaterials 475
- Pharmaceutical Science 124
- Immunology 397
- Biomedical Engineering 789
- Oncology 253
Countries citing papers authored by Conglian Yang
This map shows the geographic impact of Conglian Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Conglian Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Conglian Yang more than expected).
Fields of papers citing papers by Conglian Yang
This network shows the impact of papers produced by Conglian Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Conglian Yang. The network helps show where Conglian Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Conglian Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 325 | |
| 2 | 2019 | 196 | |
| 3 | 2021 | 135 | |
| 4 | 2020 | 99 | |
| 5 | 2019 | 74 | |
| 6 | 2021 | 61 | |
| 7 | 2022 | 53 | |
| 8 | 2021 | 51 | |
| 9 | 2017 | 47 | |
| 10 | 2021 | 42 | |
| 11 | 2018 | 36 | |
| 12 | 2024 | 31 | |
| 13 | 2019 | 28 | |
| 14 | 2022 | 28 | |
| 15 | 2018 | 28 | |
| 16 | 2018 | 26 | |
| 17 | 2023 | 24 | |
| 18 | 2018 | 23 | |
| 19 | 2024 | 23 | |
| 20 | 2021 | 21 |
About Conglian Yang
Conglian Yang is a scholar working on Biomedical Engineering, Immunology, Molecular Biology, Biomaterials and Oncology, having authored 51 papers that have together received 1.7k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (25 papers), Nanoparticle-Based Drug Delivery (14 papers), Immunotherapy and Immune Responses (14 papers), Extracellular vesicles in disease (10 papers), Immune cells in cancer (7 papers), CAR-T cell therapy research (6 papers), RNA Interference and Gene Delivery (6 papers) and Graphene and Nanomaterials Applications (5 papers). The work is most often cited by research in Biomaterials (475 citations), Pharmaceutical Science (124 citations), Immunology (397 citations), Biomedical Engineering (789 citations) and Oncology (253 citations). Conglian Yang has collaborated with scholars based in China, Sweden and Macao. Frequent co-authors include Zhiping Zhang, Tingting Wu, Li Kong, Zhiping Zhang, Yan Qi, Qi Qiao, Xianya Qin, Lihuan Shang, Dan Zhang and Qingle Song. Their work appears in journals such as Journal of Controlled Release, Nano Today, Acta Pharmaceutica Sinica B, ACS Applied Materials & Interfaces and Chemical Engineering Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.